abstract |
The invention provides a pharmaceutical composition which comprises either a pemafibrate, a salt thereof or a solvate thereof, and which has excellent homogeneity. This pharmaceutical composition comprises 0.017 to 4.2% by weight of either pemafibrate or salt thereof or solvate thereof, in terms of free pemafibrate for the total mass of pharmaceutical composition. |